Mainz Biomed B.V. 斩获莱茵兰-普法尔茨州开发银行资助 推进胰腺癌筛查技术创新

华尔街洞察
Jul 15

德国莱茵兰-普法尔茨州开发银行(Investitions- und Strukturbank Rheinland-Pfalz, ISB)宣布将通过创新与技术扶持计划,为Mainz Biomed B.V.的胰腺癌筛查项目提供高达项目总成本50%的公共资金支持。该项政府资助彰显了该公司基于血液样本的无创性早期胰腺癌筛查技术的科学价值与社会意义,将显著加速该检测方案的研发进程。

此次资助具有明确的定向性,资金将专项用于支持Mainz Biomed B.V.的研发项目。州政府的资金注入不仅验证了该检测技术的创新潜力,更凸显了其在提升重大疾病早期诊断能力方面的战略价值。该检测技术旨在通过突破性的筛查手段,实现胰腺癌的早期发现,从而有效改善患者预后。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10